Clinical trials sponsored by Instituto Mexicano del Seguro Social

Phase breakdown

Conditions studied

Recruiting trials led by Instituto Mexicano del Seguro Social

• Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
  NCT06602622 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: Male · 2 locations
• Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
  NCT07073846 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
  NCT07678268 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery
  NCT07000539 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
  NCT07031063 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Instituto Mexicano del Seguro Social recruiting for?

Instituto Mexicano del Seguro Social is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.